MNT -- The Cardiac Research Institute of the Masonic Medical Research Laboratory (MMRL) of Utica NY today announced the publication of a research paper in the Journal of the American College of Cardiology showing, for the first time, a potent effect of the combination of two drugs, ranolazine and dronedarone, to produce a safe and effective means of suppressing atrial fibrillation (AF) in experimental models of AF. The study was conducted in collaboration with Gilead Sciences, Inc. of Foster City, CA.
